<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Apolipoprotein E alleles in sporadic inclusion-body myositis and hereditary inclusion-body myopathy</title>
			</titleStmt>
			<publicationStmt>
				<publisher>Wiley</publisher>
				<availability status="unknown"><p>Copyright Wiley</p>
				</availability>
				<date type="published" when="1996-08">1996-08</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Valerie</forename><surname>Askanas</surname></persName>
						</author>
						<author>
							<persName><forename type="first">W</forename><surname>King</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Massimiliano</forename><surname>Mirabella</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Janis</forename><surname>Mcferrin</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Karl</forename><forename type="middle">H</forename><surname>Weisgraber</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD,?</roleName><forename type="first">Ann</forename><forename type="middle">M</forename><surname>Saunders</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD,$</roleName><forename type="first">Allen</forename><forename type="middle">D</forename><surname>Roses</surname></persName>
						</author>
						<title level="a" type="main">Apolipoprotein E alleles in sporadic inclusion-body myositis and hereditary inclusion-body myopathy</title>
					</analytic>
					<monogr>
						<title level="j" type="main">Annals of Neurology</title>
						<title level="j" type="abbrev">Ann Neurol.</title>
						<idno type="ISSN">0364-5134</idno>
						<idno type="eISSN">1531-8249</idno>
						<imprint>
							<publisher>Wiley</publisher>
							<biblScope unit="volume">40</biblScope>
							<biblScope unit="issue">2</biblScope>
							<biblScope unit="page" from="264" to="264"/>
							<date type="published" when="1996-08" />
						</imprint>
					</monogr>
					<idno type="MD5">3962E1D38B5807BDC8BEFCA095FFF4CA</idno>
					<idno type="DOI">10.1002/ana.410400223</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2" ident="GROBID" when="2023-03-30T18:12+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract/>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>and Janis McFerrin, BS* In the recent issue of Annals, Garlepp and co-workers <ref type="bibr">[I]</ref> reported increased frequency of apolipoprotein (apoE) 4 allele in sporadic inclusion-body myositis (s-IBM), based on studies performed in 14 Australian white patients <ref type="bibr">[I]</ref>. In contrast, Harrington and associates <ref type="bibr" target="#b1">[2]</ref> reported no increase of apoE 4 allele frequency in 11 s-IBM patients from the United Kingdom. ApoE is associated histopathologically with neurofibrillary tangles of Alzheimer's disease (AD) <ref type="bibr" target="#b2">[ 3 ]</ref> .</p><p>An increased frequency of the apoE 4 allele has been demonstrated in both late-onset-familial and sporadic AD <ref type="bibr">([4]</ref>, reviewed in reference 5). Because the muscle-fiber phenotype of s-IBM and hereditary inclusion-body myopathy (h-IBM) strikingly resembles that of AD brain, including abnormal accumulations of apoE <ref type="bibr" target="#b5">[6]</ref>, P-amyloid protein <ref type="bibr" target="#b6">[7]</ref>, hyperphosphorylated T [S], and other proteins (reviewed in reference 9 ) , it is important to establish whether an increased frequency of the apoE 4 allele is also associated with s-and/ or h-IBM.</p><p>We studied distribution of the apoE. alleles in 11 patients with s-IBM and 12 with h-IBM. s-1BM patients included 1 Pakistani, 2 Chinese, 1 Latino, and 7 white patients. Among h-IBM patients, 10 were Persian Jews and 1 was Pakistani. All s-and h-IBM patients had their diagnosis confirmed by our established diagnostic criteria IS]. The 35 disease-control patients included those with amyotrophic lateral sclerosis, progressive muscular arrophy, myasthenia gravis, polymyositis, various peripheral' neuropathies, spastic paraparesis plus epilepsy, and morphologically nonspecific rnyopathies. DNA was extracted and apoE alleles studied :according to described methods <ref type="bibr" target="#b3">[ 4 ]</ref> , without knowiedge of the patients' diagnoses.</p><p>There was no increased frequency ofapoE 4 allele in either s-or h-IBM (Table <ref type="table">)</ref>. Our studies demonstrate that among our patients the frequency of the apoE 4 allele is not increased in either s-or h-IBM. Therefore, increased apoE 4 does not appear to be a risk factor for the IBMs.</p><p>The reason for the unusual similarity between pathology of TBM muscle and AD brain is not known, but a cascade </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Apolipoprotein E Alleles in Sporadic Inclusion-Body Myositis and Hereditary Inclusion-Body Myopathy</head><note type="other">ApoE</note></div><figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head></head><label></label><figDesc>ApoE= apolipoprotein E; s-IBM = sporadic inclusion-body myositis; h-IBM = hereditary inclusion-body myopathy.of similar pathogenic steps occurring in the muscle fiber and neuron, but provoked by different causes, is a possibility. A tissue-specific intracellular aging change could be a necessary requirement in both the IBMs and AD.</figDesc><table><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>"USC Neuromziscular Center</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Department of Neurology</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>University of Southern California School of Medicine</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Good Samaritan Hospital</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Los Angeles, C4 90017-1912</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>?Gladstone Institute of Cardiovascular Disease</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Universiq o f California</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>San Francisco, CA 941 10</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>$Division of Neurology</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Duke University Medical Center</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Durham, NC 2771 0</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="2">Allele</cell></row><row><cell></cell><cell></cell><cell>Median</cell><cell></cell><cell cols="2">Frequencies</cell></row><row><cell></cell><cell>Number</cell><cell>Age</cell><cell></cell><cell></cell></row><row><cell>Patients</cell><cell cols="2">of Alleles (yr)</cell><cell>E2</cell><cell>E3</cell><cell>E4</cell></row><row><cell>S-IBM</cell><cell>22</cell><cell>67</cell><cell cols="3">0.09 0.86 0.05</cell></row><row><cell>h-IBM</cell><cell>24</cell><cell>38</cell><cell cols="3">0.08 0.87 0.05</cell></row><row><cell cols="2">Disease control 70</cell><cell>65</cell><cell cols="3">0.10 0.74 0.11</cell></row></table></figure>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Reply</head><p>Michael J. Garlepp, PhD, and Frank L. Mastaglia, M D We note with interest the results presented by Askanas and colleagues in which they report that the incidence of the apolipoprotein E (apoE) ~4 allele in their patients with inclusion-body myositis (IBM) was not increased compared with controls. This study and the previous two published studies [ 1, 21, which have addressed this issue, have suffered from the obvious limitation that relatively few cases were available for analysis. This may be one reason for the discrepancy in reported results. However, other explanations are possible.</p><p>IBM may well be heterogeneous in its etiology, and the final manifestation as inclusion-body myopathy, with or without associated inflammation, may be reached via more 264 Copyright 0 1996 by the American Neurological Association </p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Apolipoprorein E &amp;4 in inclusion body myositis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Garlepp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Tabarias</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">M</forename><surname>Van Bockxmeer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="957" to="959" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Apolipoprotein E type E4 allele frequency is not increased in patienrs wirh sporadic inclusion-body myositis</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Harrington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Chan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurosci Lett</title>
		<imprint>
			<biblScope unit="volume">995</biblScope>
			<biblScope unit="page" from="35" to="38" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Apolipoprotein E immunoreaccivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer&apos;s disease and kuru plaque amyloid in Creutzfeld-Jakob disease</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Namba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tomonaga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kawasaki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain Res</title>
		<imprint>
			<biblScope unit="volume">541</biblScope>
			<biblScope unit="page" from="163" to="166" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Association of apolipoprotein E allele ~4 with late-onset familial and sporadic Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Saunders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Strittmatter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Schmcchel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page">472</biblScope>
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Perspective: on the metabolism of apolipoprotein E and the Alzheimer diseases</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Roses</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Enp Neurol</title>
		<imprint>
			<biblScope unit="volume">132</biblScope>
			<biblScope unit="page" from="149" to="156" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Apolipoprotein E immunoreactive deposits in inclusion-body muscle diseases</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mirabella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">343</biblScope>
			<biblScope unit="page" from="364" to="365" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Light-and electronniicroscopic localization of P-amyloid protein in muscle biopsies of patients with inclusion-body myositis</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">141</biblScope>
			<biblScope unit="page" from="31" to="36" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Twisted tubulofilaments of inclusion-body myositis muscle resemble paired helical filaments of Alzheimer brain and contain hyperphosphorylated tau</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bilak</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">144</biblScope>
			<biblScope unit="page" from="177" to="187" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">New advances in the understanding of sporadic inclusion-body myositis and hereditary inclusion-body myopathics</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Rheumatol</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="486" to="496" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
